Loading...

UTHR UNITED THERAPEUTICS CORP Investments/Divestments 8-K Filing

NTD

THR

UNITED THERAPEUTICS CORP

(UTHR)

2023 8-K

Show Summary

Summary

Earnings Releases

Debt-Equity Swaps

Earnings Update

Investor Presentation

Earnings Announcement

Earnings Report

Annual Meeting of Shareholders

Earnings Release

Credit Agreement Extension

Share Repurchase Program

Patent Litigation

Earnings and Lawsuit Announ...

Patent Cancellation Decision

License Agreement Extension

Earnings Report

Earnings Release

Amendment and Restatement o...

Earnings Report

Bylaws Amendments

Credit Agreement Extension

Earnings Report

Regulation FD Disclosure

External Links:

United Therapeutics Corporation extended its exclusive license agreement with Eli Lilly and Company for the U.S. marketing, promotion, and sale of Adcirca tablets until December 31, 2026.

AI Assistant

UNITED THERAPEUTICS CORP

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.